Cross-reactivity of the V3-specific antibodies with the human C1q

被引:0
作者
Petkovic, M [1 ]
Metlas, R
机构
[1] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Leipzig, Germany
[2] Diapharm, R&D Div, YU-11000 Belgrade, Yugoslavia
[3] Diapharm Ltd, Guernsey BY4 EJ, England
来源
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES | 2001年 / 56卷 / 11-12期
关键词
human C1q; HIV-1(NY5); third hypervariable region;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been previously shown that the sequence similarity between a portion of the envelope glycoprotein 120 (gp120) from the human immunodeficiency virus type-1 (HIV-1) and several types of human collagen and collagen-like molecules exists. That observation led to the suggestion that the antibodies against the third hypervariable region (V3) of HIV-1 gp120 (V3-specific antibodies) might have a role in the autoimmune phenomena observed in HIV-infected persons. In this study we have examined the cross-reactivity of the V3-specific antibodies purified from sera of HIV-infected individuals, sera obtained from the rheumatoid arthritis and systemic lupus erythematosus patients, as well as from the sera of healthy volunteers with the separate chains of a subcomponent of the first component of the human complement system, C1q. Our results show that the V3-specific antibodies are present in the sera of the HIV-infected individuals, patients suffering of the systemic autoimmune diseases as well as in the sera of healthy volunteers. Whereas these antibodies appeared in the HIV+-sera after antigen challenge, those present in the HIV-- sera probably represent the antibodies that are cross-reactive with the antigen. V3-reactive antibodies can be purified by affinity chromatography and they were highly specific for the V3-peptide. Additionally, they showed cross-reactivity with the separate chains of the human C1q as well as with the chicken collagen type VI. Possible physiological implications are discussed.
引用
收藏
页码:1135 / 1143
页数:9
相关论文
共 33 条
[1]   ANTIBODIES TO HUMAN NATIVE AND DENATURED COLLAGENS IN SYNOVIAL-FLUIDS OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
ANDRIOPOULOS, NA ;
MESTECKY, J ;
MILLER, EJ ;
BENNETT, JC .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1976, 6 (02) :209-212
[2]  
CLAGUE RB, 1984, ARTHRITIS RHEUM, V27, P1370, DOI 10.1002/art.1780271207
[3]   SUBCLASS DISTRIBUTION OF IGA AND IGG ANTIBODIES AGAINST C1Q IN PATIENTS WITH RHEUMATIC DISEASES [J].
COREMANS, IEM ;
DAHA, MR ;
VANDERVOORT, EAM ;
SIEGERT, CEH ;
BREEDVELD, FC .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (04) :391-397
[4]  
DCRUZ DP, 1995, J RHEUMATOL, V22, P1669
[5]  
DEBARI VA, 1994, J CLIN IMMUNOASSAY, V17, P118
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS RATHER THAN HEPATITIS-C VIRUS-INFECTION IS RELEVANT TO THE DEVELOPMENT OF AN ANTICARDIOLIPIN ANTIBODY [J].
GOTOH, M ;
MATSUDA, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (03) :220-222
[7]  
GRANT MD, 1990, J IMMUNOL, V144, P1241
[8]   ENZYMATIC ALTERATION OF C1Q, THE COLLAGEN-LIKE SUBCOMPONENT OF THE 1ST COMPONENT OF COMPLEMENT, LEADS TO CROSS-REACTIVITY WITH TYPE-II COLLAGEN [J].
HEINZ, HP ;
BRACKERTZ, D ;
LOOS, M .
FEBS LETTERS, 1988, 228 (02) :332-336
[9]   COMMON EPITOPES IN C1Q AND COLLAGEN TYPE-II [J].
HEINZ, HP ;
RUBIN, K ;
LAURELL, AB ;
LOOS, M .
MOLECULAR IMMUNOLOGY, 1989, 26 (02) :163-169
[10]   RHEUMATOID FACTORS, B-CELLS AND IMMUNOGLOBULIN GENES [J].
JEFFERIS, R .
BRITISH MEDICAL BULLETIN, 1995, 51 (02) :312-331